Else Kröner Excellence Fellowships

The Else Kröner Excellence Fellowships grant clinicians at senior consultant level a two-year leave of absence for an intensive research phase.
Exzellenz-Stipendien: Funding for Accredited Clinician Scientists

Scientific work is equally linked to university facilities for physicians facing special challenges and problems. One of these lies in the fact that the demands posed by clinical work in the course of a clinical career do not allow for any interrelated continuous period of research in order to focus on a scientific research project.

The Else Kröner-Fresenius-Stiftung foundation regularly awards six individual fellowships within the entire field of medicine – each for a term of two years – to physicians following conclusion of their advanced training to become specialists. The fellowship is endowed with a total of EUR 300,000, of which up to 80% can be utilised for the recipient’s own salary according to scale or collective agreement. Applicants must be able to produce evidence of outstanding research achievements and be clinically active in a position of responsibility. Six fellowships are awarded nationwide. Interested physicians are requested to personally apply.

Please always note our current calls for proposals for this funding line. You will find them on the website under "Current Topics/Call for Poposals".
 

Submitting the Paper of the Month:
We invite all project managers, fellowship recipients and members of graduate study programs to submit their publications that have emerged from funding as Paper of the Month. You can find more information here. You can find an overview of the Paper of the Month here.  

 

Anne Asschenfeldt
Anne Asschenfeldt
Scientific Funding: Ongoing Project Funding and Fellowships

2022

PD Dr. Juan Carlos Baldermann, Zentrum für Neurologie und Psychiatrie, Klinik und Poliklinik für Neurologie, Universitätsklinikum Köln

Entstehung und Detektion von Impulsivität: Erkenntnisse aus transdiagnostischer tiefer Hirnstimulation und multimodaler Bildgebung

 

PD Dr. David Brenner, Neurologische Universitätsklinik Ulm

Charakterisierung von mit Mutationen im NEK1-Gen assoziierter amyotropher Lateralsklerose

 

Dr. Sebastian Dieter, Abteilung für Medizinische Onkologie, Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Universitätsklinikum Heidelberg

Untersuchung von Resistenzmechanismen NRG1-getriebener Tumoren gegenüber Afatinib und Entwicklung therapeutischer Ansätze zur Resistenz-Überwindung

 

PD Dr. Ibrahim El-Battrawy, Bergmannsheil Universitätsklinikum Bochum, Ruhr-Universität Bochum

Klinische und genetische Ursachen des plötzlichen Herztodes nach Ausschluss struktureller Herzerkrankungen in Deutschland

PD Dr. Cornelius Engelmann, Charité – Universitätsmedizin Berlin; Campus Virchow Klinikum, Klinik für Innere Medizin m.S. Hepatologie und Gastroenterologie

Die Rolle hepatozellulärer Seneszenz bei der Progression von chronischen Lebererkrankungen

Dr. Daniel Erny, Institut für Neuropathologie, Universitätsklinikum Freiburg

Die Rolle der Mikroglia im translationalen 5xFAD Wildling-Mausmodell für Morbus Alzheimer

PD Dr. Mareike Frick, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité – Campus Virchow Klinikum

Molekulare und klinische Charakterisierung von Langzeit-Folgen in Krebsüberlebenden

 

PD Dr. Dipl.-Phys. Daniel Paech, Klinik für Neuroradiologie, Universitätsklinikum Bonn

Entwicklung und klinische Translation neuer Imaging Biomarker zur neuroonkologischen Diagnostik

Dr. Turgay Saritas, Med. Klinik 2 (Nephrologie), Uniklinik RWTH Aachen

Transkriptionsfaktor RelA als therapeutischer Ansatzpunkt bei der Nieren- und Herzfibrose

 

2021

Prof. Dr. Tobias Böttler, Department of Internal Medicine II, University Hospital Freiburg

Excellence Fellowship: Impact of antigen recognition and immunosuppression on pathogen-specific follicular T helper cells

A brief description can be found on our website in the menu Currently Funded Projects.

PD Dr. Markus Heppt, Department of Dermatology, Universitätsklinikum Erlangen

Excellence Fellowship: Identification of novel targets for personalized treatment in metastatic uveal melanoma

A brief description can be found on our website in the menu Currently Funded Projects.

PD Dr. Johann Jende, Heidelberg University Hospital

Excellence Fellowship: Ultra-high field MR neurography

A brief description can be found on our website in the menu Currently Funded Projects.

Dr. Karl-Philipp Rommel, Heart Center Leipzig at University of Leipzig

Heart failure with preserved ejection fraction – developement of therapeutic concepts by pathomechanistic characterization, clinical phenotyping and prevention

A brief description can be found on our website in the menu Currently Funded Projects.

PD Dr. Sebastian Steven, Department for Cardiology, Cardiology I, University Medical Center Mainz

Excellence Fellowship: Active celiac disease as promoter of cardiovascular morbidity: exploration of underlying mechanisms and effect of therapeutic intervention

A brief description can be found on our website in the menu Currently Funded Projects.

Prof. Dr. Oliver Weigert, Medizinische Klinik und Poliklinik III – Hämatologie und Onkologie, Klinikum der LMU München

Exzellenzstipendium: Molekulare Mechanismen von Tumorzellinteraktionen beim follikulären Lymphom

A brief description can be found on our website in the menu Currently Funded Projects.

2020

PD Dr. Nataliya Di Donato, University Hospital Carl Gustav Carus at the Dresden University of Technology, Institute for Clinical Genetics

Excellence Fellowship: Non-muscle actin filaments and their role in health and illness

Inherited or spontaneously occurring “de novo” mutations in the actin genes ACTB and ACTG1 can lead to development disorders and organ dysplasias. These so-called non-muscle actinopathies (NMA) belong to the rare illnesses. Within the framework of the project PD Dr. Nataliya Di Donato addresses the mechanisms that lead to NMA and researches the correlations between the genetic modifications and pathologies that arise from them. The aim is to enable better treatment strategies to be developed for patients in the future.

You can find more information here.

PD Dr. med. Robert Schulz, Clinic and Polyclinic for Neurology, University Hospital Hamburg-Eppendorf

Excellence Fellowship: Non-invasive brain stimulation of the posterior parietal cortex – a new approach toward promoting recovery after a stroke?

Non-invasive brain stimulation of the motor cortex represents a potentially innovative treatment method toward promoting recovery in the case of patients who have had a stroke. However, it displays a high interindividual variability in its level of effectiveness. PD Dr. Robert Schulz studies to what extent a direct current (DC) stimulation of a specific region of the parietal lobe might present a new, alternative therapeutic approach.

You can find more information here.

PD Dr. Franziska Hopfner, MHH University Hospital in Hanover, Clinic for Neurology

Excellence Fellowship: Genetic and epigenetic architecture in cerebral tissue in the case of multiple system atrophy

In her research study project PD Dr. Franziska Hopfner concerns herself with multiple system atrophy (MSA), a neurodegenerative disease from the group of parkinsonian syndromes. Until now there have not been any treatment options to curtail the disease’s rapid progression. With the help of molecular-biological methods Hopfner is going to compare cerebral tissue from MSA patients with other parkinsonian syndromes, as well as with healthy controls, and then analyze the findings to attain a better understanding of disease mechanisms at the molecular level.

You can find more information here.

PD Dr. Pascal Johann, Augsburg University Hospital, 1st Clinic for Children and Adolescents, Pediatric Oncology

Excellence Fellowship: Overcoming resistance mechanisms in rhabdoid tumors by means of single-cell transcriptome sequencing

PD Dr. Pascal Johann focuses on rhabdoid tumors, a highly aggressive tumor illness that mainly occurs in small children. With the help of single-cell sequencing Johann researches the molecular causes of resistance to therapy for these tumors. For his outstanding research work he has received inter alia the “Württembergischer Krebspreis”, an award for cancer research, and the “Dr. Hildegard Dinter-Lutz Forschungspreis”, a prize awarded by the German Society for Pediatric Hematology and Oncology (GPOH).

Overview of current Else Kröner Excellence Fellowships

Benjamin Knier, Technical University of Munich

Excellence Fellowship: Optical coherence tomography Angiography as a prognostic factor in patients with multiple sclerosis (2019)

Sven Pischke, University Hospital Hamburg-Eppendorf

Excellence Fellowship: Examination of extrahepatic manifestations of hepatitis E virus infections (2019)

Michael Sommerauer, University Hospital Köln

Excellence Fellowship: Multimodal imaging and sleep assessments in Parkinson’s disease at different disease stages: pre-motor, early motor and late motor (2019)